Invokana Lawsuit Plaintiff Alleges Drug Caused Her To Develop Potentially Life-Threatening Diabetic Ketoacidosis

March 24, 2016 – – TheProductLawyers.com reports on a lawsuit filed against Johnson & Johnson subdivision Janssen Pharmaceuticals under case number 1:15-cv-00636 in the Southern District Of Alabama. The lawsuit plaintiff notes in her complaint that she has connected her use of new-generation diabetes drug Invokana to the development of diabetic ketoacidosis. Further details found in court documents show that the woman claims that she used the SGLT2 inhibitor drug beginning in December of 2014, and, not long after, developed a potentially life-threatening medical condition called diabetic ketoacidosis.

Diabetic ketoacidosis is dangerous, especially if it remains untreated. The medical condition is caused when the body’s bloodstream develops a surplus of toxic acid (ketones). The condition has been known to develop suddenly; sometimes in only 24 hour’s time, and has caused other patients to become comatose or pass away.

The U.S. Food and Drug Administration (FDA) has discussed this possible problem, asking those who use Invokana or other similar SGLT2 class inhibitor drugs to be on the lookout for possible signs of developing diabetic ketoacidosis. According to the Mayo Clinic, signs of diabetic ketoacidosis can consist of “excessive thirst, frequent urination, nausea and vomiting, abdominal pain, shortness of breath, fruity-scented breath, and confusion.”

Additional details from the woman’s lawsuit state that she reports that she was never made aware of the possible risks of developing diabetic ketoacidosis while taking Invokana. She also claims that Janssen Pharmaceuticals (Johnson & Johnson) showed negligence by neglecting to properly warn medical professionals and patients of these potential side effects. Since the filing of this lawsuit, the FDA has also issued a safety notice regarding the potential connection, and has required the drug’s manufacturer to make changes to its warning labels which will better reflect certain possible side effects.

The attorneys of Banville Law understand the concern surrounding these potential side effects for patients currently depending upon treatment for diabetes type-2. They are dedicated to keeping the public adequately informed on all important Invokana news. To better attain this, they sponsor TheProductLawyers.com, a resource website for anyone with questions. They are also working to help ensure that patients who believe they have suffered from adverse health events because of their use of Invokana or other similar SGLT2 inhibitor class drugs will be provided with the opportunity to fully investigate their legal rights. Affected individuals could be entitled to substantial compensation through legal action. To help those deserving of justice, the attorneys of Banville Law are also offering free legal consultations for affected individuals at this time.

To request further information on Invokana lawsuits, or to ask questions, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60008871